SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marty who wrote (378)9/26/1998 10:16:00 PM
From: Mad2   of 857
 
Marty, as you can see from the last post, the institutional and mutual fund holdings for HEB increased by a net 400,000 during the 2nd quarter. However 1,700,000 shares are held by two Dreyfus funds, Aggressive and Premire of which this guy Schonberg ran. As Barrons reported in July he has been put on leave. One of his holdings Chromatics Color had allready tanked at the time of the article (Asensio targeted). I suspect Asensio got onto this one via the link with Dreyfus as well as HEB's listing on the Berlin Stock Exchange. I understand that compelling reasons exist to questions the viability of stocks that seek listing on the Berlin Exchange. Anyway I wonder what the Dreyfus people are doing with their 1,700,000 shares of HEB. We'll find out at the end of the month.
Regards, Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News